Details for New Drug Application (NDA): 071166
✉ Email this page to a colleague
NDA 071166 describes BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE, which is a drug marketed by Hospira and is included in eight NDAs. It is available from two suppliers. Additional details are available on the BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE profile page.
The generic ingredient in BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE is bupivacaine hydrochloride; epinephrine bitartrate. There are twelve drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the bupivacaine hydrochloride; epinephrine bitartrate profile page.
The generic ingredient in BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE is bupivacaine hydrochloride; epinephrine bitartrate. There are twelve drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the bupivacaine hydrochloride; epinephrine bitartrate profile page.
Summary for 071166
| Tradename: | BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE |
| Applicant: | Hospira |
| Ingredient: | bupivacaine hydrochloride; epinephrine |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 0.25%;0.005MG/ML | ||||
| Approval Date: | Jun 16, 1988 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
